微生物组定序服务的全球市场：市场规模、占有率、成长分析、按类型、按应用、按技术 - 产业预测，2023-2030 年

Global Microbiome Sequencing Services Market Size, Share, Growth Analysis, By Type(Amplicon, whole-genome), By Application(Autoimmune disorder, cancer), By Technology(Sequencing by synthesis, sequencing by ligation) - Industry Forecast 2023-2030

出版日期: 2023年11月28日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2021年微生物定序服务的全球市场规模为12.6亿美元，从2022年的13.9亿美元成长到2030年和预测期（2023-2030）的31.3亿美元，预计复合年增长率为10.7% 2019年。

在两个关键因素的推动下，全球微生物组定序服务市场预计将在未来几年显着增长：对基于基因组的肠道研究的日益关注以及对次世代定序仪(NGS) 的需求不断增长。微生物组包括人体及其周围环境中存在的细菌、真菌、病毒和原生生物，已成为研究人员的焦点。宏基因组定序对不同生物体的遗传资讯进行顺序定序，已被用来识别特定微生物组内的微生物。微生物组定序有望显着改变疾病的诊断、治疗和预后，并引起科学界的广泛关注。 NGS 和生物资讯学演算法等先进方法的整合揭示了微生物组内复杂的相互作用，并彻底改变了临床微生物学和感染疾病研究。研究机构正在积极开发尖端工具来增强微生物组定序，例如元转录检测器（MTD）和低成本宏基因定序配合措施等。这些旨在简化资料评估和实现高解析度分析的进步有助于微生物定序服务市场的加速成长。此外，开发具有成本效益的解决方案和降低测试成本预计将推动低收入和新兴国家的更广泛采用，从而推动这些地区的市场扩张。

微生物组定序服务全球市场区隔分析

微生物组定序服务的全球市场按类型、应用、技术和地区进行细分。根据类型，市场分为放大器、全基因组、鸟枪定序等。根据应用，市场分为自体免疫疾病、癌症、胃肠道疾病等。根据技术，市场分为 SBS、SBL、 Sanger定序等。从区域来看，市场分为北美、欧洲、亚太地区、中东和非洲以及拉丁美洲。

全球微生物组定序服务市场的驱动因素

人们越来越认识到微生物组对人类健康和疾病的影响

微生物组定序市场的主要驱动力是人们日益认识到微生物组对人类健康和疾病有深远的影响。微生物群与多种健康状况之间存在着明确的联繫，包括胃肠道疾病、自体免疫疾病和癌症。随着研究人员和医疗保健专业人员寻求在诊断、治疗和个人化医疗方面的应用，这种不断加深的理解正在推动对微生物组定序服务不断增长的需求，并推动市场成长。我就是。

全球微生物组定序服务市场的抑制因素

微生物组的复杂性和多样性：微生物组定序市场的一个重要抑制因素源自于微生物组本身固有的复杂性和变异性。微生物组表现出高度多样性，个体差异受到用餐、生活方式和环境等因素的影响。这种多样性对微生物组定序资料的标准化和解释提出了挑战。微生物组分析缺乏标准化方案和参考资料资料库可能会导致不一致并影响观察的可靠性和可重复性。此外，缺乏对微生物组资料功能影响的了解可能会阻碍普及和利用。克服这些挑战并建立强有力的调查方法和标准对于微生物定序的持续发展至关重要。

微生物组定序服务的全球市场趋势

日益关注个人化医疗和精准治疗：微生物组定序市场的一个显着趋势是越来越关注个人化医疗和精准治疗。对微生物组在人类健康中的作用的深入了解将注意力集中在根据个体独特的微生物组组成定制治疗和干预措施上。这一趋势正在推动先进测序技术、生物资讯学工具和资料分析平台的发展，以实现微生物组的准确分析和分析。将微生物组资料与临床和遗传资讯结合，有助于考虑个别微生物组资讯的个人化医疗方法，从而实现有针对性和有效的治疗性介入。

执行摘要
调查方法
母市场分析
主要市场考察
- 技术分析
- 价格分析
- 供应链分析
- 价值链分析
- 市场生态系统
- 智慧财产权分析
- 贸易分析
- Start-Ups分析
- 原料分析
- 创新矩阵
- 研发线产品分析
- 总体经济指标
- 主要投资分析
- 关键成功因素
- 竞争程度
市场动态及展望
- 市场动态
  - 促进因素
  - 机会
  - 抑制因素
  - 任务
- 监管形势
- 波特的分析
- 对未来中断的特殊考察
全球微生物组定序服务市场：按类型
- 市场概况
- 放大器
- 全基因组
- 鸟枪法定序等
全球微生物组定序服务市场：依应用分类
- 市场概况
- 自体免疫疾病
- 癌症
- 胃肠道疾病等
全球微生物组定序服务市场：依技术分类
- 市场概况
- SBS
- SBL
- Sanger定序等
按地区分類的全球微生物组定序服务市场规模
- 市场概况
- 北美洲
  - 美国
  - 加拿大
- 欧洲
  - 德国
  - 西班牙
  - 法国
  - 英国
  - 其他欧洲国家地区
- 亚太地区
  - 中国
  - 印度
  - 日本
  - 韩国
  - 其他亚太地区
- 拉丁美洲
  - 巴西
  - 其他拉丁美洲地区
- 中东和非洲 (MEA)
  - 海湾合作委员会国家
  - 南非
  - 其他中东/非洲地区
竞争形势
- 前5名企业对比
- 主要企业市场定位（2021年）
- 主要市场参与者所采取的策略
- 关键成功策略
- 近期市集活动
- 主要企业市场占有率（2021年）
主要企业简介
- Microbiome Insights Inc.（Canada）
- Baseclear BV（Netherlands）
- Clinical-Microbiomics A/S（Denmark）
- Merieux NutriSciences Corporation（US）
- MR DNA（US）
- Metabiomics Corp.（US）
- Rancho BioSciences（US）
- Second Genome（US）
- Zymo Research Corporation（US）
- uBiome, Inc.（US）
- Illumina, Inc.（US）
- Thermo Fisher Scientific Inc.（US）
- QIAGEN NV（Netherlands）
- Oxford Nanopore Technologies Ltd.（UK）
- BGI Genomics Co., Ltd.（China）
- CosmosID Inc.（US）
- Diversigen Inc.（US）
- Molecular Research LP（US）
- Microbiome Therapeutics, LLC（US）
- Bio-Rad Laboratories, Inc.（US）

简介目录

Product Code: SQMIG35J2091

Global Microbiome Sequencing Services Market size was valued at USD 1.26 billion in 2021 and is poised to grow from USD 1.39 billion in 2022 to USD 3.13 billion by 2030, growing at a CAGR of 10.7% in the forecast period (2023-2030).

The global market for microbiome sequencing services is poised for substantial growth in the coming years, driven by two key factors: the increasing focus on genomics-based gut studies and the growing demand for Next-generation Sequencing (NGS). Microbiome, encompassing bacteria, fungi, viruses, and protists in and on the human body and the surrounding environment, has become a focal point for researchers. Metagenomics sequencing, a process involving continuous sequencing of genetic information from diverse organisms, is employed to identify microorganisms within a specific microbiome. Microbiome sequencing holds significant promise in revolutionizing disease diagnosis, treatment, and prognosis, gaining widespread attention in the scientific community. The integration of advanced methodologies like NGS and bioinformatics algorithms has transformed clinical microbiology and infectious disease research, illuminating the intricate interactions within the microbiome. Research institutions are actively developing cutting-edge tools to enhance microbiome sequencing analysis, exemplified by initiatives such as the meta-transcriptome detector (MTD) and low-cost metagenome sequencing technology. These advancements, aimed at simplifying data evaluation and enabling high-resolution analysis, contribute to the accelerating growth of the microbiome sequencing services market. Moreover, the development of cost-effective solutions and declining testing costs is anticipated to drive increased adoption in low-income and emerging countries, fostering market expansion in these regions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Microbiome Sequencing Services Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data.

Global Microbiome Sequencing Services Market Segmental Analysis

The Global Microbiome Sequencing Services Market is segmented by type, application, technology and region. Based on type, the market can be segmented into amplicon, whole-genome, shotgun sequencing and others. Based on application, the market is segmented into autoimmune disorder, cancer, gastrointestinal disorders and others. Based on technology, the market can be segmented into sequencing by synthesis, sequencing by ligation, sanger sequencing and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Microbiome Sequencing Services Market

Increasing Recognition of Microbiome's Impact on Human Health and Disease

A primary driver for the microbiome sequencing market is the heightened recognition of the microbiome's profound influence on human health and disease. Associations between the microbiome and various health conditions, such as gastrointestinal disorders, autoimmune diseases, and cancer, have been established. This growing understanding prompts a rising demand for microbiome sequencing services as researchers and healthcare professionals explore its applications in diagnosis, treatment, and personalized medicine, propelling market growth.

Restraints in the Global Microbiome Sequencing Services Market

Complexity and Variability of the Microbiome: A significant restraint in the microbiome sequencing market stems from the inherent complexity and variability of the microbiome itself. The microbiome exhibits high diversity, with individual variations influenced by factors like diet, lifestyle, and the environment. This diversity poses challenges in standardizing and interpreting microbiome sequencing data. The absence of standardized protocols and reference databases for microbiome analysis can result in inconsistencies, impacting the reliability and reproducibility of findings. Additionally, the evolving understanding of the functional implications of microbiome data may impede widespread adoption and utilization in clinical settings. Overcoming these challenges and establishing robust methodologies and standards are pivotal for sustained growth in microbiome sequencing.

Market Trends of the Global Microbiome Sequencing Services Market

Increasing Focus on Personalized Medicine and Precision Therapeutics: A noteworthy trend in the microbiome sequencing market is the growing emphasis on personalized medicine and precision therapeutics. Deeper insights into the microbiome's role in human health lead to a focus on tailoring treatments and interventions based on an individual's unique microbiome composition. This trend drives the development of advanced sequencing technologies, bioinformatics tools, and data analytics platforms for accurate profiling and analysis of the microbiome. Integration of microbiome data with clinical and genetic information facilitates personalized medicine approaches, considering an individual's microbiome profile for targeted and effective therapeutic interventions.

Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
  - Drivers
  - Opportunities
  - Restraints
  - Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
  - Drivers
  - Opportunities
  - Restraints
  - Challenges
- Regulatory Landscape
- Porters Analysis
  - Competitive rivalry
  - Threat of Substitute Products
  - Bargaining Power of Buyers
  - Threat of New Entrants
  - Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
  - Political Impact
  - Economic Impact
  - Social Impact
  - Technical Impact
  - Environmental Impact
  - Legal Impact
Global Microbiome Sequencing Services Market by Type
- Market Overview
- Amplicon
- whole-genome
- shotgun sequencing and others
Global Microbiome Sequencing Services Market by Application
- Market Overview
- Autoimmune disorder
- cancer
- gastrointestinal disorders and others
Global Microbiome Sequencing Services Market by Technology
- Market Overview
- Sequencing by synthesis
- sequencing by ligation
- sanger sequencing and others
Global Microbiome Sequencing Services Market Size by Region
- Market Overview
- North America
  - USA
  - Canada
- Europe
  - Germany
  - Spain
  - France
  - UK
  - Rest of Europe
- Asia Pacific
  - China
  - India
  - Japan
  - South Korea
  - Rest of Asia-Pacific
- Latin America
  - Brazil
  - Rest of Latin America
- Middle East & Africa (MEA)
  - GCC Countries
  - South Africa
  - Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
  - By Development
  - By Company
  - By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Microbiome Insights Inc. (Canada)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Baseclear BV (Netherlands)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Clinical-Microbiomics A/S (Denmark)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Merieux NutriSciences Corporation (US)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- MR DNA (US)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Metabiomics Corp. (US)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Rancho BioSciences (US)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Second Genome (US)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Zymo Research Corporation (US)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- uBiome, Inc. (US)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Illumina, Inc. (US)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Thermo Fisher Scientific Inc. (US)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- QIAGEN N.V. (Netherlands)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Oxford Nanopore Technologies Ltd. (UK)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- BGI Genomics Co., Ltd. (China)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- CosmosID Inc. (US)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Diversigen Inc. (US)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Molecular Research LP (US)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Microbiome Therapeutics, LLC (US)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Bio-Rad Laboratories, Inc. (US)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments